Literature DB >> 1444079

Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.

D Utku1, L S Atmaca.   

Abstract

We evaluated 164 eyes of 87 patients with diabetes mellitus compared with 50 eyes from 25 healthy subjects as the control group. We compared 87 patients with diabetes mellitus (164 eyes) in relation to their duration of diabetes, fundus findings, visual acuity, and color vision defects. In all patients, color vision defects were determined using the Farnsworth-Munsell 100-hue test, and the total error score was established on the basis of age norms from subjects without diabetes. No color vision defect was detected in the control group. In the diabetic group, fundus degeneration and color vision defects were observed and correlated with the duration of diabetes. The dominant color defect was of the blue-yellow type.

Entities:  

Mesh:

Year:  1992        PMID: 1444079

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  6 in total

1.  Extent of foveal tritanopia in diabetes mellitus.

Authors:  N Davies; A Morland
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  The Diabetes Visual Function Supplement Study (DiVFuSS).

Authors:  A Paul Chous; Stuart P Richer; Jeffry D Gerson; Renu A Kowluru
Journal:  Br J Ophthalmol       Date:  2015-06-18       Impact factor: 4.638

3.  Changes in retinal layers in type 1 diabetes mellitus without retinopathy measured by spectral domain and swept source OCTs.

Authors:  Elvira Orduna-Hospital; Ana Sanchez-Cano; Lorena Perdices; Javier Acha; Elena María Lopez-Alaminos; Isabel Pinilla
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 4.  A critical review: Psychophysical assessments of diabetic retinopathy.

Authors:  Xing D Chen; Thomas W Gardner
Journal:  Surv Ophthalmol       Date:  2020-08-29       Impact factor: 6.048

5.  Influence of retinopathy on the achromatic and chromatic vision of patients with type 2 diabetes.

Authors:  Luciana Cristina O Andrade; Givago S Souza; Eliza Maria C B Lacerda; Maira Tst Nazima; Anderson R Rodrigues; Liudmila M Otero; Francineide Ps Pena; Luiz Carlos L Silveira; Maria Izabel T Côrtes
Journal:  BMC Ophthalmol       Date:  2014-08-31       Impact factor: 2.209

6.  Inactivation of Endothelial ADAM17 Reduces Retinal Ischemia-Reperfusion Induced Neuronal and Vascular Damage.

Authors:  Diana R Gutsaeva; Lamiaa Shalaby; Folami L Powell; Menaka C Thounaojam; Hossameldin Abouhish; Sara A Wetzstein; Ravirajsinh N Jadeja; Hang Fai Kwok; Pamela M Martin; Manuela Bartoli
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.